Log In
Print this Print this

estetrol (E4)/drospirenone (DRSP)

  Manage Alerts
Collapse Summary General Information
Company Pantarhei Bioscience B.V.
DescriptionOral combination of 15 mg estetrol and 3 mg drospirenon
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationContraception
Indication DetailsPrevent contraception
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today